Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
- In the 12 months to Nov 19, 2026, insiders of Windward Bio Group filed 4 open-market purchases (about $69.8M, in 3 filings, by 3 people) and 0 open-market sales (about $0, in 0 filings, by 0 people). One Form 4 can list many transactions.
- In the 12 months before that, they filed 0 open-market purchases (about $0, in 0 filings) and 0 open-market sales (about $0, in 0 filings).
- The largest purchase: ORBIMED ADVISORS LLC, Director, about $20M, filed Nov 18, 2026.
Company reports, price and press
- Press coverage listed by Finnhub: "Windward Bio to Participate at the Jefferies London Global Healthcare Conference" (Yahoo, Nov 17, 2026).
- Press coverage listed by Finnhub: "Innovative Immunology Biotech Windward Bio Lists on Nasdaq" (Yahoo, Nov 14, 2026).
- Press coverage listed by Finnhub: "Windward Bio Announces Pricing of Initial Public Offering" (Yahoo, Nov 12, 2026).
- WWB closed at $22.64 on Nov 18, 2026, the last session on or before the end of the period.
- From Nov 13, 2026 to Nov 18, 2026, the close moved from $28.50 to $22.64, a change of −20.6%.
Things to keep in mind
- These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
- A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
- Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
- Share price moves are listed as context only; the filing does not explain them and other news can move a price.
- This describes public filings. It is not investment advice.